Experienced in Vitamin D Deficiency

Dr. Antoinette M. Moran

Pediatric Endocrinology | Endocrinology | Pediatrics
Fairview Express Care
717 Delaware St Se, Suite 340, 
Minneapolis, MN 
Accepting New Patients
Experienced in Vitamin D Deficiency
Fairview Express Care
717 Delaware St Se, Suite 340, 
Minneapolis, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Antoinette Moran is a Pediatric Endocrinologist and an Endocrinologist in Minneapolis, Minnesota. Dr. Moran is rated as an Experienced provider by MediFind in the treatment of Vitamin D Deficiency. Her top areas of expertise are Type 1 Diabetes (T1D), Congenital Hyperinsulinism, Chronic Pancreatitis, Pancreatectomy, and Islet Cell Transplantation. Dr. Moran is currently accepting new patients.

Her clinical research consists of co-authoring 118 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Vitamin D Deficiency.

Specialties
Pediatric Endocrinology
Endocrinology
Pediatrics
Licenses
Pediatrics in MN
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Metropolitan Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
PreferredOne
  • HMO
  • OTHER COMMERCIAL
Sanford Health
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 9 Less Insurance Carriers -

Locations

FAIRVIEW EXPRESS CARE
717 Delaware St Se, Suite 340, Minneapolis, MN 55414
Other Locations
FAIRVIEW EXPRESS CARE
2450 Riverside Ave, Minneapolis, MN 55454

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 Administered Subcutaneously to Patients With Type 1 Diabetes Mellitus
A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041 Administered Subcutaneously to Patients With Type 1 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: May 20, 2025
Intervention Type: Other, Drug
Study Drugs: Pre-Proinsulin, TGF-Beta1, IL-10, IL-2
Study Phase: Phase 1
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer)
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer)
Enrollment Status: Completed
Publish Date: November 27, 2024
Intervention Type: Drug, Device
Study Drug: Verapamil
Study Phase: Phase 3
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes
CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 Diabetes
Enrollment Status: Completed
Publish Date: June 06, 2024
Intervention Type: Drug
Study Drug: CTLA4-Ig (Abatacept)
Study Phase: Phase 2
A Prospective, Multi-center, Phase 1b/2a Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Association With Teplizumab in Patients With Clinical Recent-onset Type 1 Diabetes Mellitus (T1D)
A Prospective, Multi-center, Phase 1b/2a Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Association With Teplizumab in Patients With Clinical Recent-onset Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Completed
Publish Date: February 01, 2023
Intervention Type: Biological, Drug
Study Drugs: AG019 - Low Dose, Teplizumab, AG019 - High Dose, AG019 - Low or High Dose
Study Phase: Phase 1/Phase 2
Preserving Beta-Cell Function With Tocilizumab in New-onset Type 1 Diabetes (ITN058AI)
Preserving Beta-Cell Function With Tocilizumab in New-onset Type 1 Diabetes (ITN058AI)
Enrollment Status: Completed
Publish Date: September 08, 2021
Intervention Type: Drug, Other
Study Phase: Phase 2
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
A Prospective Randomized Placebo-Controlled Double Blind Clinical Trial to Evaluate the Safety and Efficacy of CLBS03 (Autologous Ex Vivo Expanded Polyclonal Regulatory T-cells) in Adolescents With Recent Onset Type 1 Diabetes Mellitus (T1DM)
Enrollment Status: Completed
Publish Date: January 08, 2021
Intervention Type: Biological
Study Phase: Phase 2
View 5 Less Clinical Trials

118 Total Publications

Personalized Hemoglobin A1c Shows Better Correlation with Mean Glucose than Laboratory Hemoglobin A1c in Ugandan Youth with Type 1 Diabetes, but Mean Glucose Is Not Clinically Useful in This Population Due to Extreme Glucose Variability.
Personalized Hemoglobin A1c Shows Better Correlation with Mean Glucose than Laboratory Hemoglobin A1c in Ugandan Youth with Type 1 Diabetes, but Mean Glucose Is Not Clinically Useful in This Population Due to Extreme Glucose Variability.
Journal: Diabetes technology & therapeutics
Published: March 20, 2025
Similar Doctors
Advanced in Vitamin D Deficiency
Dr. Joseph M. Gonzalez
Endocrinology
Advanced in Vitamin D Deficiency
Dr. Joseph M. Gonzalez
Endocrinology

Minnesota Center For Obesity Metabolism And Endocrinology PA

1185 Town Centre Dr, Suite 220, 
Eagan, MN 
 (10.5 miles away)
651-379-1600
Languages Spoken:
English
See accepted insurances

Joseph Gonzalez is an Endocrinologist in Eagan, Minnesota. Dr. Gonzalez is rated as a Distinguished provider by MediFind in the treatment of Vitamin D Deficiency. His top areas of expertise are Obesity, Sheehan Syndrome, Hypogonadotropic Hypogonadism, and Panhypopituitarism.

Advanced in Vitamin D Deficiency
Dr. Adepero O. Okulaja
Pediatrics | Internal Medicine
Advanced in Vitamin D Deficiency
Dr. Adepero O. Okulaja
Pediatrics | Internal Medicine
6545 France Ave S, Suite 335, 
Edina, MN 
 (7.8 miles away)
612-333-4834
Languages Spoken:
English, Yoruba
See accepted insurances
Accepting New Patients

Adepero Okulaja is a primary care provider, practicing in Pediatrics and Internal Medicine in Edina, Minnesota. Dr. Okulaja is rated as a Distinguished provider by MediFind in the treatment of Vitamin D Deficiency. Her top areas of expertise are Scurvy, Pellagra, Molybdenum Cofactor Deficiency (MoCD), and Pyridoxine Deficiency. Dr. Okulaja is currently accepting new patients.

Advanced in Vitamin D Deficiency
Dr. Crispin Semakula
Endocrinology
Advanced in Vitamin D Deficiency
Dr. Crispin Semakula
Endocrinology

Novacare Outpatient Rehabilitation East, Inc.

480 Hwy 96 E, Suite 120, 
Vadnais Heights, MN 
 (10.3 miles away)
651-482-8486
Languages Spoken:
English
See accepted insurances

Crispin Semakula is an Endocrinologist in Vadnais Heights, Minnesota. Dr. Semakula is rated as an Experienced provider by MediFind in the treatment of Vitamin D Deficiency. His top areas of expertise are Vitamin D Deficiency, Type 2 Diabetes (T2D), Hypothyroidism, and Eunuchoidism Familial Hypogonadotropic.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Moran's expertise for a condition
ConditionClose
    View All 12 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile